Skip to main content

Table 1 Characteristics of healthy controls, chronic fatigue syndrome (CFS) patients, Q fever fatigue syndrome (QFS) patients, and asymptomatic Q fever seropositive controls

From: A possible role for mitochondrial-derived peptides humanin and MOTS-c in patients with Q fever fatigue syndrome and chronic fatigue syndrome

Characteristics

Healthy controls

(n = 10)

CFS

(n = 10)

QFS

(n = 10)

Q fever seropositives

(n = 10)

Male sex, number (%)

5 (50)

5 (50)

5 (50)

5 (50)

Age, years

Median (IQR)

54 (37–61)

48 (41–52)

43 (40–58)

50 (43–57)

Duration of symptoms, monthsa

Median (IQR)

–

110 (31–253)

78 (62–87)

–

CIS subscale fatigue severity score, mean ± SD

–

51 ± 5.1

52 ± 4.1

–

SIP-8 total score, mean ± SD

–

1600 ± 735.0

1474 ± 483.7

–

  1. QFS Q fever fatigue syndrome, CFS chronic fatigue syndrome, IQR interquartile range; CIS Checklist Individual Strength, SD standard deviation, SIP-8 Sickness Impact Profile-8
  2. aSymptom duration: time onset of symptoms until blood sampling